|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US8114414B2
(en)
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US7662396B2
(en)
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
AU2001255196A1
(en)
|
2000-03-29 |
2001-10-08 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing immunogenicity of antigens
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
JP2005527240A
(ja)
|
2002-05-29 |
2005-09-15 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
弱毒リステリア種とこれを使用する方法
|
|
WO2004062597A2
(en)
|
2003-01-09 |
2004-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
DK1789559T3
(en)
|
2004-08-13 |
2015-08-24 |
Univ Pennsylvania |
Methods to construct vaccines with no antibiotic resistance
|
|
US7855064B2
(en)
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
US7858097B2
(en)
*
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
WO2006045110A2
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Inc. |
High cell density process for growth of listeria
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US8241636B2
(en)
|
2006-08-15 |
2012-08-14 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
WO2008130551A2
(en)
|
2007-04-16 |
2008-10-30 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free listeria strains and methods for constructing and using same
|
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
WO2009143085A1
(en)
*
|
2008-05-19 |
2009-11-26 |
Anza Therapeutics, Inc. |
Compositions comprising prfa*mutant listeria and methods of use thereof
|
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
ES2741730T3
(es)
|
2008-05-19 |
2020-02-12 |
Advaxis Inc |
Sistema de administración doble para antígenos heterólogos que comprende una cepa de Listeria recombinante atenuada por la mutación de dal/dat y la deleción de ActA que comprende una molécula de ácido nucleico que codifica una proteína de fusión de listeriolisina O - antígeno prostático específico
|
|
US9084747B2
(en)
|
2009-11-11 |
2015-07-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors
|
|
JP2011529077A
(ja)
*
|
2008-07-24 |
2011-12-01 |
アデュロ バイオテック |
Ｃ型肝炎の治療のための組成物および方法
|
|
ES2637068T3
(es)
|
2009-03-04 |
2017-10-10 |
The Trustees Of The University Of Pennsylvania |
Composiciones que comprenden factores angiogénicos y métodos de uso de las mismas
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
US20110305724A1
(en)
|
2010-04-19 |
2011-12-15 |
Yvonne Paterson |
Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
|
|
US9226958B2
(en)
|
2010-10-01 |
2016-01-05 |
University Of Georgia Research Foundation, Inc. |
Use of Listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
|
|
EP2640842B1
(en)
|
2010-11-17 |
2018-05-30 |
Aduro Biotech, Inc. |
Methods and compositions for inducing an immune response to egfrviii
|
|
AU2012229218B2
(en)
*
|
2011-03-11 |
2017-03-02 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
HK1205944A1
(en)
|
2012-03-12 |
2015-12-31 |
阿德瓦希斯公司 |
Suppressor cell function inhibition following listeria vaccine treatment
|
|
JP2017511796A
(ja)
|
2014-02-18 |
2017-04-27 |
アドバクシス， インコーポレイテッド |
多標的免疫療法を目的とするバイオマーカー
|
|
KR20240038103A
(ko)
|
2014-02-25 |
2024-03-22 |
어드박시스, 인크. |
Ｈｅｒ2/ｎｅｕ 과발현 종양의 치료를 위한 조성물 및 방법
|
|
MA39717A
(fr)
|
2014-03-05 |
2017-01-11 |
Advaxis Inc |
Procédés et compositions pour accroître le rapport des lymphocytes t effecteurs aux lymphocytes t régulateurs
|
|
SG10202011841WA
(en)
|
2014-04-24 |
2021-01-28 |
Advaxis Inc |
Recombinant listeria vaccine strains and methods of producing the same
|
|
CA2947677A1
(en)
|
2014-05-02 |
2015-11-05 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of her-2-positive cancers
|
|
MX2017000838A
(es)
|
2014-07-18 |
2017-09-01 |
Advaxis Inc |
Cepa de listeria recombinante que expresa proteinas de fusion con antigenos heterologos y metodos para el uso de estas.
|
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
|
WO2016011362A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Listeria-based immunogenic compositions for eliciting anti-tumor responses
|
|
EP3193921A4
(en)
|
2014-07-18 |
2018-04-25 |
Advaxis, Inc. |
Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
|
|
EP3207142A4
(en)
|
2014-10-14 |
2018-07-04 |
The Trustees Of The University Of Pennsylvania |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
MA41217A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Polythérapies ayant des souches de listeria recombinées
|
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
WO2016126878A2
(en)
|
2015-02-03 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Listeria-based immunomodulation
|
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
|
US20180104284A1
(en)
|
2015-05-13 |
2018-04-19 |
Advaxis, Inc. |
Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
|
|
KR20180026670A
(ko)
|
2015-05-26 |
2018-03-13 |
어드박시스, 인크. |
맞춤형 전달 벡터-기반의 면역 요법 및 이의 용도
|
|
KR20180027501A
(ko)
|
2015-06-24 |
2018-03-14 |
어드박시스, 인크. |
맞춤형 전달 벡터-기반 면역 요법을 위한 제조 장치 및 공정
|
|
MA42841A
(fr)
|
2015-09-15 |
2018-07-25 |
Advaxis Inc |
Procédé de fabrication d'une formulation immunothérapeutique comprenant une souche de listeria de recombinaison
|
|
WO2017048850A1
(en)
|
2015-09-15 |
2017-03-23 |
Advaxis, Inc. |
Listeria-based immunogenic compositions and methods of use thereof in cancer prevention and treatment
|
|
JP2018527382A
(ja)
|
2015-09-17 |
2018-09-20 |
アドバクシス， インコーポレイテッド |
組み換え型リステリアワクチン株および癌免疫療法におけるその使用方法
|
|
MX2018004598A
(es)
|
2015-10-14 |
2018-11-29 |
Advaxis Inc |
Cepas vacunales recombinantes de listeria y métodos para usar las mismas en la inmunoterapia contra el cáncer.
|
|
WO2017085691A1
(en)
|
2015-11-20 |
2017-05-26 |
Advaxis, Inc. |
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
US20180360940A1
(en)
|
2015-12-16 |
2018-12-20 |
Advaxis, Inc. |
Listeria-based immunotherapy and methods of use thereof
|
|
MX2018009225A
(es)
|
2016-01-27 |
2019-08-21 |
Advaxis Inc |
Inmunoterapia basada en vectores de distribución personalizados y usos de la misma.
|
|
CN109641945A
(zh)
|
2016-07-05 |
2019-04-16 |
阿德瓦希斯公司 |
包含维尔姆斯瘤蛋白抗原的基于李斯特菌的免疫原性组合物及其使用方法
|
|
MA46721A
(fr)
|
2016-11-07 |
2019-09-11 |
Advaxis Inc |
Combinaison d'un vaccin à base de listeria avec des anticorps anti-ctla-4 ou anti-cd137
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
US11897927B2
(en)
|
2016-11-30 |
2024-02-13 |
Advaxis, Inc. |
Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
|
|
WO2018129306A1
(en)
|
2017-01-05 |
2018-07-12 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|